Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 17, Pages 9566
Publisher
MDPI AG
Online
2021-09-07
DOI
10.3390/ijms22179566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteogenomic and metabolomic characterization of human glioblastoma
- (2021) Liang-Bo Wang et al. CANCER CELL
- GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
- (2020) Sascha Marx et al. JOURNAL OF NEURO-ONCOLOGY
- Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
- (2019) Niklas Schäfer et al. Journal of Translational Medicine
- Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
- (2019) Anne Dirkse et al. Nature Communications
- Connecting Metainflammation and Neuroinflammation Through the PTN-MK-RPTPβ/ζ Axis: Relevance in Therapeutic Development
- (2019) Gonzalo Herradon et al. Frontiers in Pharmacology
- Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues
- (2019) Prospero Civita et al. Frontiers in Oncology
- Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
- (2019) Liu Shi et al. Alzheimers & Dementia
- Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
- (2019) Yaoqing Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin
- (2019) Chuan He Yang et al. CANCER LETTERS
- The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
- (2019) Arne Christians et al. Acta Neuropathologica Communications
- Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma
- (2019) Johannes Graumann et al. Frontiers in Oncology
- A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer
- (2018) David Mysona et al. GYNECOLOGIC ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
- (2017) Bin Sun et al. Oncotarget
- mixOmics: An R package for ‘omics feature selection and multiple data integration
- (2017) Florian Rohart et al. PLoS Computational Biology
- Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
- (2017) Jennifer Peyling Wang et al. Journal of Cancer
- Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
- (2017) Dongya Zhang et al. Scientific Reports
- Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells
- (2016) Satoshi Okawa et al. STEM CELLS
- Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study
- (2016) Selina Tsim et al. BMJ Open
- A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
- (2016) Priscila F. de Aquino et al. Frontiers in Oncology
- Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research
- (2015) Qiang Tian et al. MOLECULAR & CELLULAR PROTEOMICS
- Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK)
- (2015) Jingyan Luo et al. MOLECULAR BIOLOGY OF THE CELL
- A practical review of prognostic correlations of molecular biomarkers in glioblastoma
- (2015) Michael Karsy et al. Neurosurgical Focus
- Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies
- (2015) Liang Xia et al. Oncotarget
- Short Hairpin RNA-Mediated Fibronectin Knockdown Delays Tumor Growth in a Mouse Glioma Model
- (2015) Sadhak Sengupta et al. NEOPLASIA
- The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse Glioma
- (2014) J. T. Huse et al. CLINICAL CANCER RESEARCH
- Co-expression of midkine and pleiotrophin predicts poor survival in human glioma
- (2014) Jinyang Ma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy
- (2014) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Structure and function of midkine as the basis of its pharmacological effects
- (2013) T Muramatsu BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer
- (2013) Huifang Hao et al. PLoS One
- Differential phosphoproteome of the striatum from pleiotrophin knockout and midkine knockout mice treated with amphetamine: Correlations with amphetamine-induced neurotoxicity
- (2013) Esther Gramage et al. TOXICOLOGY
- Midkine Promotes Neuroblastoma through Notch2 Signaling
- (2012) S. Kishida et al. CANCER RESEARCH
- Life's Simple Measures: Unlocking the Proteome
- (2012) Edward Brody et al. JOURNAL OF MOLECULAR BIOLOGY
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Protein Signature of Lung Cancer Tissues
- (2012) Michael R. Mehan et al. PLoS One
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
- (2012) Rachel M. Ostroff et al. PLoS One
- Midkine confers Adriamycin resistance in human gastric cancer cells
- (2012) Ying-ying Xu et al. TUMOR BIOLOGY
- The creatine kinase system and pleiotropic effects of creatine
- (2011) Theo Wallimann et al. AMINO ACIDS
- Glioblastoma cell secretome: Analysis of three glioblastoma cell lines reveal 148 non-redundant proteins
- (2011) Ravindra V. Polisetty et al. Journal of Proteomics
- Advances in human proteomics at high scale with the SOMAscan proteomics platform
- (2011) Larry Gold et al. New Biotechnology
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors
- (2010) Tamina Rawnaq et al. ANNALS OF SURGICAL ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
- (2010) P. Sreekanthreddy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Sparse Partial Least Squares Classification for High Dimensional Data
- (2010) Dongjun Chung et al. Statistical Applications in Genetics and Molecular Biology
- Aptamers and the RNA World, Past and Present
- (2010) L. Gold et al. Cold Spring Harbor Perspectives in Biology
- Midkine: A Novel Prognostic Biomarker for Cancer
- (2010) Hirofumi Jono et al. Cancers
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
- (2009) Macoura Gadji et al. CANCER GENETICS AND CYTOGENETICS
- Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population
- (2008) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Disease: temozolomide and glioblastoma—look to the future
- (2008) Maciej M Mrugala et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started